Thursday, April 02, 2026 | 01:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Metropolis Healthcare Ltd News

Next phase of growth is about improving utilisation: Surendran Chemmenkotil

In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy

Next phase of growth is about improving utilisation: Surendran Chemmenkotil
Updated On : 05 Feb 2026 | 5:41 PM IST

Metropolis Q3FY26 results: Profit jumps 32%, revenue rises nearly 26%

India's second-largest pathology chain reported strong year-on-year profit growth in the December quarter, supported by higher test volumes, preventive care demand and specialised diagnostics

Metropolis Q3FY26 results: Profit jumps 32%, revenue rises nearly 26%
Updated On : 04 Feb 2026 | 8:13 PM IST

Metropolis Healthcare shares jump 6% on 26% revenue growth in Q3 update

Metropolis Healthcare shares rose 6 per cent it reported a 26 per cent Y-o-Y jump in its standalone revenue in the third quarter of the current financial year

Metropolis Healthcare shares jump 6% on 26% revenue growth in Q3 update
Updated On : 05 Jan 2026 | 1:18 PM IST

Metropolis launches GLP-1 monitoring test packages, targets obesity market

Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment

Metropolis launches GLP-1 monitoring test packages, targets obesity market
Updated On : 02 Dec 2025 | 6:11 PM IST

Metropolis Q2 results: Profit up 13% on higher patient, test volumes

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Metropolis Q2 results: Profit up 13% on higher patient, test volumes
Updated On : 04 Nov 2025 | 10:04 PM IST

Will Apollo, Max, Metropolis outshine peers in Q2? Here's what analysts say

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

Will Apollo, Max, Metropolis outshine peers in Q2? Here's what analysts say
Updated On : 09 Oct 2025 | 8:37 AM IST

Metropolis Healthcare rises 4% on releasing Q2 update; check details

According to the company filing, it delivered a 23 per cent year-on-year (Y-o-Y) revenue growth at the consolidated level, driven by robust momentum in preventive health check-ups

Metropolis Healthcare rises 4% on releasing Q2 update; check details
Updated On : 07 Oct 2025 | 12:36 PM IST